Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia

Bone Marrow Transplantation

Volumn 33, Issue 1, 2004, Pages 39-45

  Sharathkumar, A ^a   Saunders, E F ^a   Dror, Y ^a   Grant, R ^a   Greenberg, M ^a   Weitzman, S ^a   Chan, H ^a   Calderwood, S ^b   Freedman, M H ^a   Doyle, John ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Allogeneic bone marrow transplantation; Children; Philadelphia positive (Ph+) ALL

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; STEROID; TENIPOSIDE; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA REMISSION; LONG TERM CARE; MALE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0742306749     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704319     Document Type: Article

References (33)

1. Crist W, Carroll A, Shuster J et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 1990; 76: 489-494.
2. Fletcher JA, Lynch EA, Kimball VM et al. Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 1991; 77: 435-439.
3. Uckun FM, Nachman JB, Sather HN et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies. A report from the Children's Cancer Group. Cancer 1998; 83: 2030-2039.
4. Linker CA, Levitt LJ, O'Donnell M et al. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 1991; 78: 2814-2822.
5. Gotz G, Weh HJ, Walter TA et al. Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol 1992; 64: 97-100.
6. Carella AM, Frassoni F, Pollicardo N et al. Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Br J Haematol 1995; 89: 535-538.
7. Reece DE, Buskard NA, Hill RS et al. Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemia. Leuk Res 1986; 10: 457-459.
8. Forman SJ, O'Donnell MR, Nademanee AP et al. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1987; 70: 587-588.
9. Barrett AJ, Horowitz MM, Ash RC et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992; 79: 3067-3070.
10. Chao NJ, Blume KG, Forman SJ, Snyder DS. Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1995; 85: 3353-3354 (letter).
11. Dunlop LC, Powles R, Singhal S et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1996; 17: 365-369.
12. Snyder DS, Nademanee AP, O'Donnell MR et al. Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. Leukemia 1999; 13: 2053-2058.
13. Stockschläder M, Hegewisch-Becker S, Krüger W et al. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1995; 16: 663-667.
14. Kroger N, Kniger W, Walker-Backhans G et al. Intensified conditioning regimen for in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Bone Marrow Transplant 1998; 22: 1029-1033.
15. Marks DI, Bird JM, Cornish JM et al. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 931-936.
16. Sierra J, Radich J, Hansen JA et al. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1997; 90: 1410-1414.
17. +) acute lymphocytic leukemia (ALL) using alternative donors. Blood 1992; 80 (Suppl. 1): 65a (abstract #249).
18. Mori T, Manabe A, Tsuchida M et al. Allogeneic bone marrow transplantation in first remission rescues children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13. Med Pediatr Oncol 2001; 37: 426-431.
19. Ribeiro RC, Broniscer A, Rivera GK et al. Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia 1997; 11: 1493-1496.
20. Aricò M, Valsecchi MG, Camitta B et al. Outcome of treatment in children with Philadelphia chromosome positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998-1006.
21. +) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998; 92: 2730-2741.
22. Bennett JM, Catovsky D, Daniel M-T et al. Proposals for the classification of the acute leukemias. Brit J Haematol 1976; 33: 451-458.
23. Chan LC, Pegram SM, Greaves MF. Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemia. Lancet 1985; 1: 475-479.
24. Mitelman F (ed) ISCN (1995). An International System for Human Cytogenetic Nomenclature. Karger: Basel, 1995.
25. Rivera G, Dahl GV, Bowman WP et al. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia. Cancer 1980; 46: 1727-1730.
26. Henze G, Fengler R, Hartmann R et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 1991; 78: 1166-1172.
27. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
28. Lansky SB, List MA, Lansky LL et al. The measurement of performance in childhood cancer patients. Cancer 1987; 60: 1651-1656.
29. Kaplan G, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
30. Cornelissen JJ, Carston M, Kollman C et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001; 97: 1572-1577.
31. Al-Kasim FA, Thornley I, Rolland M et al. Single-center experience with allogeneic bone marrow transplantation for acute lymphoblastic leukemia in childhood: comparable survival after matched-related and matched-unrelated donor transplants. Br J Haematol 2002; 116: 483-490.
32. Machin D, Campbell M, Fayers P, Pinol A. Sample Size Tables for Clinical Studies, 2nd edn. Balckwell Science: Malden, MA, 1997.
33. Wheeler KA, Richards SM, Bailey CC et al. Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI. Blood 2000; 96: 2412-2418.